Oral albendazole for the treatment of cutaneous larva migrans.
Cutaneous larva migrans is becoming more common in the U.K. with the popularity of tropical countries as holiday destinations. We describe the increasing use of a new benzimidazole derivative, albendazole, which is very effective in the treatment of cutaneous larva migrans. In contrast to thiabendazole, it is virtually free from side-effects and should, we feel, become the treatment of choice for this condition.
Jones
S K
SK
Department of Dermatology, Bristol Royal Infirmary, Bristol, U.K.
Reynolds
N J
NJ
Oliwiecki
S
S
Harman
R R
RR
D000284:Administration, Oral; D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D001940:Breast / Q000469:parasitology; D002081:Buttocks / Q000469:parasitology; D006801:Humans; D007815:Larva Migrans / Q000188:drug therapy* / Q000469:parasitology; D007868:Leg Dermatoses / Q000188:drug therapy / Q000469:parasitology
D015766:Albendazole